Dr. Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc, a drug discovery company focused on targeting GPCR heteromers in cancer, headquartered in Seoul, Korea, with an R&D facility in the SF Bay Area. Dr. Fung received his Ph.D. from the Stanford University School of Medicine under the mentorship of Dr. Brian Kobilka, studying the dimerization of GPCRs. Dr. Fung continued his Postdoctoral training in Dr. Kobilka’s lab contributing to the elucidation of high-resolution structures of various GPCRs. Dr. Fung has spent significant time in the industry studying membrane proteins, antibodies, and HTS methods for drug discovery. His current work is mainly focused on screening and assay development to bridge the gap between in vitro and in vivo GPCR pharmacology.
-------------------------------------------
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us who are working towards exploiting the druggability of #GPCR's. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
To build our #GPCR Ecosystem, we created various enabling outlets.
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
-------------------------------------------
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Bring in a #GPCR Consultant
